|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02269 WUXI BIO
Nominal 
32.360 +0.820 (+2.600%) Ranking Overview
Ranking based on 10 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
1
|
Buy (2)
8
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 122.00 RMB (cts) | |
| Net Profit | 4,908.34 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 5,367.84 | 132.40 | 0 | -- | 6,951.00 | 5,112.00 |
| 2027 | 6,479.49 | 160.00 | 0 | -- | 8,279.00 | 5,811.00 |
| 2028 | 8,021.50 | 192.45 | 0 | -- | 9,617.00 | 6,852.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 6,024.00 | 150.00 | -- | JP MORGAN | Overweight | 51.00 | 13/02/2026 | |
| 2026 | 5,387.68 | 146.00 | -- | JEFFERIES HK | Buy | 50.00 | 08/10/2025 | |
| 2026 | 5,448.00 | 132.00 | -- | UBS | Buy | 49.30 | 25/03/2026 | |
| 2026 | 5,325.00 | 129.00 | -- | CLSA | OutPerform | 47.30 | 26/03/2026 | |
| 2026 | 5,925.70 | 164.40 | -- | UOB | Buy | 45.00 | 26/03/2026 | |
| 2026 | 5,138.00 | 123.00 | -- | MORGAN STANLEY | Overweight | 45.00 | 03/02/2026 | |
| 2026 | 5,348.00 | 132.80 | -- | DAIWA | Buy | 42.00 | 26/03/2026 | |
| 2026 | 5,297.00 | 128.00 | -- | BANK OF AMERICA | Neutral | 39.50 | 25/03/2026 | |
| 2026 | 5,112.00 | 125.00 | -- | NOMURA | Buy | 37.36 | 28/11/2025 | |
| 2026 | 6,951.00 | 141.20 | -- | BOCI | Buy | 37.00 | 26/03/2026 | |
| 2027 | 7,266.00 | 181.00 | -- | JP MORGAN | -- | -- | 13/02/2026 | |
| 2027 | 6,460.98 | 171.00 | -- | JEFFERIES HK | -- | -- | 08/10/2025 | |
| 2027 | 6,748.00 | 163.00 | -- | UBS | -- | -- | 25/03/2026 | |
| 2027 | 6,498.00 | 157.00 | -- | CLSA | -- | -- | 26/03/2026 | |
| 2027 | 7,033.40 | 190.80 | -- | UOB | -- | -- | 26/03/2026 | |
| 2027 | 6,229.00 | 149.00 | -- | MORGAN STANLEY | -- | -- | 03/02/2026 | |
| 2027 | 6,310.00 | 156.70 | -- | DAIWA | -- | -- | 26/03/2026 | |
| 2027 | 6,010.00 | 145.00 | -- | BANK OF AMERICA | -- | -- | 25/03/2026 | |
| 2027 | 5,811.00 | 142.00 | -- | NOMURA | -- | -- | 28/11/2025 | |
| 2027 | 8,279.00 | 168.10 | -- | BOCI | -- | -- | 26/03/2026 | |
| 2028 | 8,235.00 | 199.00 | -- | UBS | -- | -- | 25/03/2026 | |
| 2028 | 7,808.00 | 189.00 | -- | CLSA | -- | -- | 26/03/2026 | |
| 2028 | 8,367.20 | 222.70 | -- | UOB | -- | -- | 26/03/2026 | |
| 2028 | 7,636.00 | 189.60 | -- | DAIWA | -- | -- | 26/03/2026 | |
| 2028 | 6,852.00 | 166.00 | -- | BANK OF AMERICA | -- | -- | 25/03/2026 | |
| 2028 | 9,617.00 | 195.30 | -- | BOCI | -- | -- | 26/03/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 27/03/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,908,343 |
| %Change | 46.252% |
| EPS / (LPS) | RMB 1.220 |
| NBV Per Share (¥) | RMB 11.430 |